Keybank National Association OH Sells 10,650 Shares of Danaher Corporation $DHR

Keybank National Association OH decreased its stake in Danaher Corporation (NYSE:DHR) by 3.0% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 339,522 shares of the conglomerate’s stock after selling 10,650 shares during the period. Keybank National Association OH’s holdings in Danaher were worth $64,373,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Root Financial Partners LLC raised its position in shares of Danaher by 97.3% in the 1st quarter. Root Financial Partners LLC now owns 1,953 shares of the conglomerate’s stock valued at $370,000 after acquiring an additional 963 shares during the period. Capital Asset Advisory Services LLC increased its stake in Danaher by 4.3% in the first quarter. Capital Asset Advisory Services LLC now owns 14,755 shares of the conglomerate’s stock valued at $2,885,000 after purchasing an additional 609 shares in the last quarter. Essex Financial Services Inc. increased its stake in Danaher by 15.6% in the first quarter. Essex Financial Services Inc. now owns 6,284 shares of the conglomerate’s stock valued at $1,191,000 after purchasing an additional 849 shares in the last quarter. CHICAGO TRUST Co NA raised its holdings in Danaher by 55.5% in the first quarter. CHICAGO TRUST Co NA now owns 10,624 shares of the conglomerate’s stock worth $2,014,000 after purchasing an additional 3,791 shares during the period. Finally, Balentine LLC raised its holdings in Danaher by 5.4% in the first quarter. Balentine LLC now owns 4,507 shares of the conglomerate’s stock worth $855,000 after purchasing an additional 232 shares during the period. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 2.1%

Shares of NYSE:DHR opened at $197.85 on Friday. The firm has a market cap of $140.03 billion, a price-to-earnings ratio of 38.27, a PEG ratio of 2.47 and a beta of 0.79. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company’s fifty day simple moving average is $178.74 and its 200 day simple moving average is $200.56. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last announced its earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same period in the prior year, the business earned $1.88 EPS. The company’s revenue for the quarter was up 3.7% compared to the same quarter last year. As a group, research analysts forecast that Danaher Corporation will post 8.44 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. Danaher’s dividend payout ratio (DPR) is presently 30.95%.

Wall Street Analysts Forecast Growth

DHR has been the subject of several research analyst reports. Royal Bank Of Canada began coverage on shares of Danaher in a report on Thursday, May 14th. They issued an “outperform” rating and a $200.00 price target for the company. Weiss Ratings downgraded Danaher from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday. Guggenheim reduced their target price on Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Barclays decreased their target price on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Finally, Evercore increased their price target on Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a report on Tuesday, April 21st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.